1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) is sponsored by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). MIRA provides support for the program of research in an investigator's laboratory that falls within the mission of NIGMS.
The goal is to increase funding efficiency by providing investigators with greater stability and flexibility over five-year grant periods, enhancing scientific productivity and the potential for important breakthroughs. This program also aims to distribute funding more widely among talented researchers. Early Stage Investigators should apply through PAR-27-032.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Public and private institutions of higher education including universities. Open to both established investigators/new investigators and early stage investigators. Early stage investigators should apply through PAR-27-032. Confirm the full requirements in the official notice before applying.
Applications for Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) are due May 26, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) is funded by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read article